Life Sciences

FDA finalizes guidance on distribution of reprints

Pharma Compliance Alert, January 14, 2009

Pharmaceutical and medical device manufacturers will find it easier to distribute journal articles detailing off-label and investigational uses of their products.

The FDA’s Good Reprint Practices for the Distribution of Medical Journal Articles and Medical or Scientific Reference Publications on Unapproved New Uses of Approved Drugs and Approved or Cleared Medical Devices U.S. eases restrictions on the distribution of articles from peer-reviewed medical and scientific journals.

Click here to read more.

Comments

0 comments on “FDA finalizes guidance on distribution of reprints

 

Most Popular